Vectron to buy protein production platform from T3S

By The Science Advisory Board staff writers

June 17, 2021 -- Vectron Biosolutions announced it recently raised $2.7 million and will buy a bacterial secretion platform from Utah-based T3S Technologies.

T3S's secretion platform is based on high-level expression followed by true secretion of proteins and will allow Vectron to boost its protein production offering, according to the company. Dynamk Capital, a growth equity and venture capital firm, led the financing round, Vectron said.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.